CDH Utopia Limited entered into an agreement to acquire a 6.07% stake in Sinovac Biotech Ltd. (NasdaqGS:SVA) from 1Globe Biomedical (Hong Kong) Company Limited for $90 million on November 24, 2020. Under the term, CDH Utopia will acquire 6 million shares of Sinovac Biotech at $15 per share. CDH Utopia Limited and 1Globe Biomedical (Hong Kong) Company Limited agrees to pay $0.15 million as termination fee. CDH Investment Advisory Private Limited acted as a guarantor to CDH Utopia Limited.